UBS Group’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.25M | Sell |
|
|||||
|
2025
Q1 | $4.38M | Buy |
|
|||||
|
2024
Q4 | $4.37M | Buy |
|
|||||
|
2024
Q3 | $4.8M | Buy |
|
|||||
|
2024
Q2 | $4.16M | Sell |
|
|||||
|
2024
Q1 | $4.21M | Buy |
|
|||||
|
2023
Q4 | $3.97M | Sell |
|
|||||
|
2023
Q3 | $4.21M | Sell |
|
|||||
|
2023
Q2 | $4.41M | Sell |
|
|||||
|
2023
Q1 | $4.92M | Sell |
|
|||||
|
2022
Q4 | $5.16M | Buy |
|
|||||
|
2022
Q3 | $4.24M | Sell |
|
|||||
|
2022
Q2 | $5.39M | Sell |
|
|||||
|
2022
Q1 | $6.96M | Buy |
|
|||||
|
2021
Q4 | $7.66M | Sell |
|
|||||
|
2021
Q3 | $8.18M | Sell |
|
|||||
|
2021
Q2 | $8.56M | Buy |
|
|||||
|
2021
Q1 | $7.13M | Sell |
|
|||||
|
2020
Q4 | $7.31M | Sell |
|
|||||
|
2020
Q3 | $7.21M | Buy |
|
|||||
|
2020
Q2 | $6.84M | Sell |
|
|||||
|
2020
Q1 | $5.68M | Sell |
|
|||||
|
2019
Q4 | $6.42M | Sell |
|
|||||
|
2019
Q3 | $6.02M | Sell |
|
|||||
|
2019
Q2 | $7.25M | Sell |
|
|||||
|
2019
Q1 | $7.25M | Sell |
|
|||||
|
2018
Q4 | $7.04M | Sell |
|
|||||
|
2018
Q3 | $9.29M | Sell |
|
|||||
|
2018
Q2 | $8.96M | Buy |
|
|||||
|
2018
Q1 | $8.81M | Sell |
|
|||||
|
2017
Q4 | $9.29M | Sell |
|
|||||
|
2017
Q3 | $24.4M | Buy |
|
|||||
|
2017
Q2 | $9.3M | Sell |
|
|||||
|
2017
Q1 | $8.99M | Sell |
|
|||||
|
2016
Q4 | $9.19M | Buy |
|
|||||
|
2016
Q3 | $9.24M | Sell |
|
|||||
|
2016
Q2 | $8.36M | Sell |
|
|||||
|
2016
Q1 | $10.8M | Sell |
|
|||||
|
2015
Q4 | $15.2M | Sell |
|
|||||
|
2015
Q3 | $15.1M | Sell |
|
|||||
|
2015
Q2 | $22.2M | Sell |
|
|||||
|
2015
Q1 | $21.3M | Sell |
|
|||||
|
2014
Q4 | $21.9M | Buy |
|